Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

C R Bard Inc (NYSE:BCR)

Delayed Data
As of Mar 24
 +1.18 / +0.47%
Today’s Change
Today|||52-Week Range
Health Technology
Medical Specialties

Company Description

C.R. Bard, Inc. designs, develops, manufactures, packages, distributes and sells medical, surgical, diagnostic and patient care devices. It sells a broad range of products to hospitals, individual healthcare professionals, extended care facilities and alternate site facilities on a global basis. The company's products include vascular, urology, oncology and surgical specialty products. The vascular products cover a range of minimally invasive devices for the treatment of peripheral vascular disease and heart arrhythmias. The urology products include basic drainage products, continence products and urological specialty products. The oncology products include devices used in the treatment and management of various cancers and other diseases and disorders. The surgical specialties products include implanted patches and fixation systems for hernia and other soft tissue repairs in addition to hemostats and surgical sealants. C. R. Bard was founded by Charles Russell Bard in 1907 and is headquartered in Murray Hill, NJ.

Contact Information

C.R. Bard, Inc. (New Jersey)
730 Central Avenue
Murray Hill New Jersey 07974
P:(908) 277-8000
Investor Relations:
(908) 277-8065



Individual stakeholders5.30%
Other institutional46.26%
Mutual fund holders45.19%

Top Executives

Tim M. RingChairman & Chief Executive Officer
John H. WeilandPresident, Chief Operating Officer & Director
Christopher S. HollandChief Financial Officer & Senior Vice President
John A. DeFordSenior VP-Science, Technology & Clinical Affairs
Patricia G. ChristianVP-Quality, Regulatory & Medical Affairs